Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2021 Jan;43(1):61-65.
doi: 10.1055/s-0040-1713803. Epub 2021 Jan 29.

Pre-eclampsia: Universal Screening or Universal Prevention for Low and Middle-Income Settings?

Affiliations
Practice Guideline

Pre-eclampsia: Universal Screening or Universal Prevention for Low and Middle-Income Settings?

Leandro Gustavo De Oliveira et al. Rev Bras Ginecol Obstet. 2021 Jan.

Abstract

Pre-eclampsia (PE) is a severe disorder that affects up to 8% of all pregnancies and represents an important cause of maternal and perinatal morbidity and mortality. The screening of the disease is a subject of studies, but the complexity and uncertainties regarding its etiology make this objective a difficult task. In addition, the costs related to screening protocols, the heterogeneity of the most affected populations and the lack of highly effective prevention methods reduce the potential of current available algorithms for screening. Thus, the National Specialized Commission of Hypertension in Pregnancy of the Brazilian Association of Gynecology and Obstetrics Federation (Febrasgo, in the Portuguese acronym) (NSC Hypertension in Pregnancy of the Febrasgo) considers that there are no screening algorithms to be implemented in the country to date and advocates that Aspirin and calcium should be widely used.

A Pré-eclâmpsia (PE) é uma doença grave que acomete ∼ 8% das gestações e representa importante causa de morbimortalidade, tanto materna quanto perinatal. O rastreamento da doença é motivo de estudos, porém a complexidade e as incertezas quanto a sua etiologia tornam esse objetivo bastante difícil. Além disso, os custos relacionados com o rastreamento, a heterogeneidade das populações mais afetadas e ainda a falta de métodos de prevenção de grande eficácia reduzem o potencial dos algoritmos de rastreamento. Assim, a Comissão Nacional Especializada sobre Hipertensão na Gravidez da Federação Brasileira das Associações de Ginecologia e Obstetrícia (CNE Hipertensão na Gravidez da FEBRASGO) considera que não há algoritmos de rastreamento que possam ser aplicados no país nesse momento e defende a utilização dos métodos de prevenção como ácido acetilsalicílico e cálcio de maneira ampla.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interests to declare.

References

    1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(03):130–137. doi: 10.1053/j.semperi.2009.02.010. - DOI - PubMed
    1. Ministério da Saúde Secretaria de Vigilância em Saúde Departamento de Análise de Saúde e Vigilância de Doenças Não Transmissíveis [Internet] Painel de monitoramento da mortalidade materna 2019[cited 2019 Dec 10]. Available from:http://svs.aids.gov.br/dantps/centrais-de-conteudos/paineis-de-monitoram...
    1. Brazilian Network of Studies on Reproductive and Perinatal Health . Passini R, Jr, Tedesco R P, Marba S T. Brazilian multicenter study on prevalence of preterm birth and associated factors. BMC Pregnancy Childbirth. 2010;10:22. doi: 10.1186/1471-2393-10-22. - DOI - PMC - PubMed
    1. Brazilian Multicenter Study on Preterm Birth study group . Souza R T, Cecatti J G, Passini R., Jr The burden of provider-initiated preterm birth and associated factors: evidence from the Brazilian Multicenter Study on Preterm Birth (EMIP) PLoS One. 2016;11(02):e0148244. doi: 10.1371/journal.pone.0148244. - DOI - PMC - PubMed
    1. Poon L C, Shennan A, Hyett J A. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145 01:1–33. doi: 10.1002/ijgo.12802. - DOI - PMC - PubMed

Publication types

LinkOut - more resources